NYSE:CRLLife Sciences
A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback
Quarterly beat and restructuring set the stage for Charles River Laboratories stock
Charles River Laboratories International (CRL) recently beat quarterly expectations and introduced a new US$1b share repurchase authorization, while simultaneously restructuring through divestitures, site closures, and workforce reductions.
See our latest analysis for Charles River Laboratories International.
Despite the recent beat, Charles River Laboratories International's 1 day share price return of 1.83%...